Projects per year
Personal profile
Research Area Keywords
- Clinical Care
- Transplantation
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
SciClone-Thymalfasin (thymosin alpha 1; Ta1) as an enhancer of vaccine response among older adults receiving booster doses of COVID-19
Mylonakis, E. (PI), Gotur, D. B. (Key Personnel) & Youssef, J. G. (Key Personnel)
10/30/24 → …
Project: Clinical Trial
-
Mitochondrial function in symptomatic chronic COVID-19 patients COVID-19 Associated Mitochondria Functional Changes in Subjects with Post-Acute Sequelae of SARS-CoV-2 Infections (PASC)
Hamilton, D. J. (PI), Kansara, A. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Single or Double Lung Transplantation (BT-L-CsA-303-FU (BOSTON-3))
Huang, H. J. (PI), Botros, M. (Key Personnel), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Huang, H. J. (PI), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
ECP - BOS - CAG-00324R2
Huang, H. J. (PI), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
Research output
- 12 Article
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation
Huang, H. J., Schechtman, K., Askar, M., Bernadt, C., Mitter, B., Dore, P., Goodarzi, A., Yau, S. W., Youssef, J. G., Witt, C. A., Byers, D. E., Vazquez-Guillamet, R., Halverson, L., Nava, R., Puri, V., Kreisel, D., Gelman, A. E. & Hachem, R. R., Mar 1 2024, In: Transplantation. 108, 3, p. 777-786 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series
Halawi, H., Harris, J. E., Goodarzi, A., Yau, S., Youssef, J. G., Botros, M. & Huang, H. J., Feb 2 2024, In: Pharmacotherapy. 44, 3, p. 283-289 7 p.Research output: Contribution to journal › Article › peer-review
-
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group, Sep 2023, In: The Lancet Respiratory Medicine. 11, 9, p. 791-803 13 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide
Youssef, J. G., Bitar, M. Z., Zahiruddin, F., Al-Saadi, M. A., Elshawwaf, M., Yau, S. W., Goodarzi, A. & Javitt, J. C., Jan 5 2022, In: Critical Care Explorations. 4, 1, p. E0607Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial∗
Youssef, J. G., Lavin, P., Schoenfeld, D. A., Lee, R. A., Lenhardt, R., Park, D. J., Fernandez, J. P., Morganroth, M. L., Javitt, J. C. & Jayaweera, D., Nov 1 2022, In: Critical Care Medicine. 50, 11, p. 1545-1554 10 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations